Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormones.
The co-existence of melanoma and pregnancy present unique questions about patient management. There have been conflicting reports over the past several decades about the implications to melanoma of pregnancy and reproductive hormones. Several recent studies, have, however, produced a reasonable consensus.
Slingluff
C L
CL
Department of Surgery, University of Virginia Health Sciences Center, Charlottesville 22908.
Reintgen
D
D
D000328:Adult; D000818:Animals; D003278:Contraceptives, Oral, Hormonal; D005260:Female; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000401:mortality*; D011379:Prognosis; D011960:Receptors, Estrogen; D012878:Skin Neoplasms / Q000401:mortality*
D003278:Contraceptives, Oral, Hormonal; D012739:Gonadal Steroid Hormones; D011960:Receptors, Estrogen